Newsletter

115180 - Qurient Co., Ltd.

115180 Summary
Biopharma
Stock Price & Overview
₩23,050 +3,400 (+17.30%) Close · Sep 4, 2026 KST
KOSDAQ | ₩KRW | Close: ₩23,050  ≈ US$16  ·  Market cap ₩0.9tn (≈ $618m)
What kstock news is. Short items on what actually happened — a filing, an order, a buyback, a result — written from the Korean filing or the Korean press for people who cannot read either. Each one puts the event against a figure from this company's own statements. No view, no rating; that is what analysis is for.

115180 News

All kstock news »
ks

Qurient approves ₩100 billion shareholder rights offering - Yonhap

Qurient Co., Ltd. (115180) approved a rights offering to raise about ₩100 billion, Yonhap reported Friday.

kstock NewsYesterday, 7:08 PM
1 item. Written from DART filings and Korean press reports; every item lists its source.

Similar to 115180

SymbolLast Price
003090Daewoong Co., Ltd.₩16,860
-2.0%
086450Dong Kook Pharmaceutical Co., Ltd.₩21,600
-0.9%
185750Chong Kun Dang Pharmaceutical Corp.₩68,000
-0.3%
476830Rznomics, Inc.₩28,200
+6.8%
003850Boryung Corporation₩9,040
+1.6%
950260Ingenia Therapeutics Inc.(reg.s)₩15,580
-1.5%
085660Chabiotech Co., Ltd.₩8,090
+2.1%
476060Onconic Therapeutics, Inc.₩16,440
-3.9%
041960Komipharm International Co., Ltd.₩9,710
+3.5%
317450Myungin Pharm₩44,650
+0.0%
Compare all 48 in Biopharma

What a US investor should know

  • Trading hours09:00–15:30 KST — 20:00–02:30 US Eastern the night before.
  • Daily limitKorean stocks can move at most ±30% in a session before trading halts.
  • Getting exposureKRX shares are not directly tradable in most US brokerage accounts. The usual routes are Korea ETFs or an international account.
  • ReportingKorean issuers file to DART, not the SEC. Half-year and quarterly reports land about 45 days after period end.